ampelopsin has been researched along with Lung Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chao, L; Cui, MX; Jiang, JF; Liu, ZR; Wu, YJ; Zhai, J; Zhao, YF | 1 |
Bai, Y; Chen, XM; Huang, G; Jia, Q; Jiang, H; Wang, F; Xie, XB; Xie, XL; Yin, JQ; Zhao, Q | 1 |
Lu, L; Qin, H; Song, CL; Wang, XX; Wu, YJ; Yang, LN | 1 |
Ahn, BN; Hong, SW; Hur, DY; Kim, D; Kim, YS; Lee, HK; Noh, MH; Park, NS; Shim, JA | 1 |
Liu, DY; Luo, GQ; Zheng, HQ | 1 |
Liu, D; Wang, L; Wang, W; Ye, Y; Zeng, S | 1 |
Bian, W; Guan, X; Jiang, J; Li, W; Sun, Y; Wang, Y; Xu, C; Yu, X; Zhang, C; Zhao, Q | 1 |
Li, W; Li, X; Wang, R; Zhang, Y; Zhou, L | 1 |
Fan, KJ; Liu, Y; Tian, XD; Wang, B; Yang, B | 1 |
Chang, JH; Chien, MH; Chow, JM; Chung, CL; Hung, WY; Kao, SJ; Lee, WJ | 1 |
10 other study(ies) available for ampelopsin and Lung Neoplasms
Article | Year |
---|---|
Ampelopsin sodium induces mitochondrial-mediated apoptosis in human lung adenocarcinoma SPC-A-1 cell line.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine Triphosphatases; Antineoplastic Agents, Phytogenic; Apoptosis; Calcium; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Flavonoids; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria | 2016 |
Ampelopsin induces apoptosis by regulating multiple c-Myc/S-phase kinase-associated protein 2/F-box and WD repeat-containing protein 7/histone deacetylase 2 pathways in human lung adenocarcinoma cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adenosine Monophosphate; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; F-Box Proteins; F-Box-WD Repeat-Containing Protein 7; Flavonoids; Gene Expression Regulation, Neoplastic; Histone Deacetylase 2; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Proto-Oncogene Proteins c-myc; RNA, Messenger; S-Phase Kinase-Associated Proteins; Signal Transduction; Ubiquitin-Protein Ligases | 2015 |
Synergistic cytotoxicity of ampelopsin sodium and carboplatin in human non-small cell lung cancer cell line SPC-A1 by G
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flavonoids; Humans; Lung Neoplasms | 2017 |
Combination treatment with erlotinib and ampelopsin overcomes erlotinib resistance in NSCLC cells via the Nox2-ROS-Bim pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Flavonoids; Humans; Lung Neoplasms; Mutation; NADPH Oxidase 2; Protein Kinase Inhibitors; Reactive Oxygen Species; RNA, Small Interfering | 2017 |
[Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro].
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Flavonoids; Lauraceae; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Plants, Medicinal; Xenograft Model Antitumor Assays | 2003 |
[Anti-tumor effects of ampelopsin on human lung cancer GLC-82 implanted in nude mice].
Topics: Animals; Antineoplastic Agents; Female; Flavonoids; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Plants, Medicinal; Time Factors | 2004 |
The mechanism of rh-endostatin-induced cardiotoxicity and its protection by dihydromyricetin[in vivo/in vitro, C57BL/6 mice, AC16 and hiPSC-CMs].
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cardiotoxicity; Drug-Related Side Effects and Adverse Reactions; Endostatins; Humans; Induced Pluripotent Stem Cells; Lung Neoplasms; Mice; Mice, Inbred C57BL; Myocytes, Cardiac | 2023 |
Dihydromyricetin suppresses tumor growth via downregulation of the EGFR/Akt/survivin signaling pathway.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Down-Regulation; ErbB Receptors; Humans; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Survivin | 2023 |
Inhibition of human lung cancer proliferation through targeting stromal fibroblasts by dihydromyricetin.
Topics: Antineoplastic Agents; Cancer-Associated Fibroblasts; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Flavonols; Humans; Lung Neoplasms; MAP Kinase Signaling System; Platelet-Derived Growth Factor; Receptors, Platelet-Derived Growth Factor; Stromal Cells | 2017 |
Suppression of reactive oxygen species-mediated ERK and JNK activation sensitizes dihydromyricetin-induced mitochondrial apoptosis in human non-small cell lung cancer.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Survival; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonols; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; Protein Kinase Inhibitors; Reactive Oxygen Species | 2017 |